BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28895473)

  • 21. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.
    El Oussini H; Bayer H; Scekic-Zahirovic J; Vercruysse P; Sinniger J; Dirrig-Grosch S; Dieterlé S; Echaniz-Laguna A; Larmet Y; Müller K; Weishaupt JH; Thal DR; van Rheenen W; van Eijk K; Lawson R; Monassier L; Maroteaux L; Roumier A; Wong PC; van den Berg LH; Ludolph AC; Veldink JH; Witting A; Dupuis L
    Acta Neuropathol; 2016 Mar; 131(3):465-80. PubMed ID: 26744351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
    Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
    BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia.
    Rossi S; Cozzolino M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Mishra PS; Dhull DK; Nalini A; Vijayalakshmi K; Sathyaprabha TN; Alladi PA; Raju TR
    J Neuroinflammation; 2016 Aug; 13(1):212. PubMed ID: 27578023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis.
    Trias E; Ibarburu S; Barreto-Núñez R; Barbeito L
    Neurosci Lett; 2017 Jan; 636():27-31. PubMed ID: 27473942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Senolytics: A Novel Strategy for Neuroprotection in ALS?
    Maximova A; Werry EL; Kassiou M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
    Perera ND; Turner BJ
    Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis.
    Shaikh AY; Martin LJ
    Neuromolecular Med; 2002; 2(1):47-60. PubMed ID: 12230304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice.
    Zhou Y; Lu Y; Fang X; Zhang J; Li J; Li S; Deng X; Yu Y; Xu R
    Neurodegener Dis; 2015; 15(1):1-12. PubMed ID: 25591625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
    Poon HF; Hensley K; Thongboonkerd V; Merchant ML; Lynn BC; Pierce WM; Klein JB; Calabrese V; Butterfield DA
    Free Radic Biol Med; 2005 Aug; 39(4):453-62. PubMed ID: 16043017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroinflammation in amyotrophic lateral sclerosis].
    Endo F; Yamanaka K
    Rinsho Shinkeigaku; 2014; 54(12):1128-31. PubMed ID: 25672727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.
    Obál I; Klausz G; Mándi Y; Deli M; Siklós L; Engelhardt JI
    J Neuroinflammation; 2016 May; 13(1):121. PubMed ID: 27220674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The multi-dimensional roles of astrocytes in ALS.
    Yamanaka K; Komine O
    Neurosci Res; 2018 Jan; 126():31-38. PubMed ID: 29054467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
    Calingasan NY; Chen J; Kiaei M; Beal MF
    Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis.
    Pehar M; Cassina P; Vargas MR; Castellanos R; Viera L; Beckman JS; Estévez AG; Barbeito L
    J Neurochem; 2004 Apr; 89(2):464-73. PubMed ID: 15056289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.
    Trias E; Ibarburu S; Barreto-Núñez R; Babdor J; Maciel TT; Guillo M; Gros L; Dubreuil P; Díaz-Amarilla P; Cassina P; Martínez-Palma L; Moura IC; Beckman JS; Hermine O; Barbeito L
    J Neuroinflammation; 2016 Jul; 13(1):177. PubMed ID: 27400786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis.
    Thonhoff JR; Simpson EP; Appel SH
    Curr Opin Neurol; 2018 Oct; 31(5):635-639. PubMed ID: 30048339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Calcium ion is a common denominator in the pathophysiological processes of amyotrophic lateral sclerosis].
    Patai R; Nógrádi B; Meszlényi V; Obál I; Engelhardt J; Siklós L
    Ideggyogy Sz; 2017 Jul; 70(7-8):247-257. PubMed ID: 29870639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.